Fidelity Investments’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Fidelity Investments’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,073,633	Closed	-$290M	–	4777
2020 Q4	$290M	Sell	8,073,633 -135,110	-2%	-$4.73M	0.03%	593
2020 Q3	$231M	Buy	8,208,743 +380,847	+5%	+$13.5M	0.02%	586
2020 Q2	$339M	Buy	7,827,896 +3,278,642	+72%	+$148M	0.04%	424
2020 Q1	$173M	Buy	4,549,254 +141,317	+3%	+$5.51M	0.02%	555
2019 Q4	$120M	Buy	+4,407,937	New	+$111M	0.01%	852

Fidelity Investments's VIE Position: Q1 2021 in Review

Fidelity Investments sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 8,073,633 shares — an estimated $290M sold.

Fidelity Investments first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $339M in Q2 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Fidelity Investments reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Fidelity Investments sold 8,073,633 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $290M.
Fidelity Investments first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Fidelity Investments's Viela Bio, Inc. Common Stock position peaked at $339M in Q2 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Fidelity Investments's 13F filing for Q1 2021, filed 14 May 2021.